Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

The Caruso Florist & Flower Delivery said they are prepared for the Valentine's Day rush. The business has been in the ...

Good Day New York covers the latest updates in A$ap Rocky's criminal proceedings, a Bronx deli is selling individual eggs and ...